Artiva Biotherapeutics (ARTV) Retained Earnings (2023 - 2025)
Historic Retained Earnings for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to -$309.8 million.
- Artiva Biotherapeutics' Retained Earnings fell 3434.52% to -$309.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$309.8 million, marking a year-over-year decrease of 3434.52%. This contributed to the annual value of -$246.7 million for FY2024, which is 3605.57% down from last year.
- Artiva Biotherapeutics' Retained Earnings amounted to -$309.8 million in Q3 2025, which was down 3434.52% from -$288.2 million recorded in Q2 2025.
- Artiva Biotherapeutics' Retained Earnings' 5-year high stood at -$181.3 million during Q4 2023, with a 5-year trough of -$309.8 million in Q3 2025.
- Moreover, its 3-year median value for Retained Earnings was -$246.7 million (2024), whereas its average is -$248.1 million.
- In the last 5 years, Artiva Biotherapeutics' Retained Earnings tumbled by 3605.57% in 2024 and then tumbled by 3434.52% in 2025.
- Quarter analysis of 3 years shows Artiva Biotherapeutics' Retained Earnings stood at -$181.3 million in 2023, then crashed by 36.06% to -$246.7 million in 2024, then fell by 25.59% to -$309.8 million in 2025.
- Its Retained Earnings was -$309.8 million in Q3 2025, compared to -$288.2 million in Q2 2025 and -$267.0 million in Q1 2025.